Bright Light Therapy for Prader-Willi Syndrome
This study is testing if Bright Light Therapy can help people with Prader-Willi Syndrome (PWS) who experience excessive daytime sleepiness. You might be able to join if you are between 6 and 88 years old, have a confirmed diagnosis of PWS, and score 12 or higher on the Epworth Sleepiness Scale (a measure of sleepiness). The study will compare Bright Light Therapy to a Sham Light (a light that looks similar but doesn't provide the same treatment). Researchers will look for improvements in your overall condition after 8 weeks. The study is currently unclear on its recruitment status and plans to enroll 50 participants.
- Study design
- This is an open-label, placebo-controlled study comparing Bright Light Therapy to a Sham Light. It aims to enroll 50 participants.
- What's involved
- You would have 8 remote visits over 8 weeks, with weekly visits after the first one. During these visits, changes in your mood, behavior, body weight, and hyperphagia (extreme hunger) will be assessed.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your overall condition will be assessed at 8 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Impact of Bright Light Therapy on Prader-Willi Syndrome
At a glance
Conditions
NCT05939453
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Maimonides Medical Center
Brooklyn, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Edward Yi, MD · PRINCIPAL_INVESTIGATOR · Maimonides Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinical Global Impression- Improvement (CGI-I)8 Weeks
A positive clinical response will be determined by a rating of 1 or 2 (Very much/Much improved) on the Clinical Global Impression- Improvement (CGI-I) scale at the end of the blinded trial.